Cofactor Genomics Claimed

Cofactor Genomics was founded after the pioneering efforts of the Human Genome Project made high-throughput, affordable human genome sequencing a reality. The founders saw that analyzing RNA offered a number of advantages over the static nature of DNA (learn more here).

Today, Cofactor Genomics is bringing precision medicine to immunotherapy by leading development of predictive diagnostics. Powered by RNA-expression models, Cofactor’s approach can characterize the microenvironment of a tumor and predict patient response to immunotherapy.